Overview

Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose

Status:
Completed
Trial end date:
2010-10-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and reactogenicity of one booster dose of a HIV candidate vaccine after administration of one oral dose of chloroquine.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Chloroquine
Chloroquine diphosphate
Vaccines